{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:26:28Z","timestamp":1790803588528,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Jilin Province Tianhua Health Public Welfare Foundation","award":["No. J2023JKJ016"],"award-info":[{"award-number":["No. J2023JKJ016"]}]},{"name":"the Jilin Province Tianhua Health Public Welfare Foundation","award":["No. J2023JKJ016"],"award-info":[{"award-number":["No. J2023JKJ016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04346-w","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:15:15Z","timestamp":1775909715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ROS-Responsive MnO2 nanozyme co-delivering cGAMP and TGF-\u03b2 inhibitor synergistically activates STING signaling and remodels the immunosuppressive thyroid cancer microenvironment"],"prefix":"10.1186","volume":"24","author":[{"given":"Guangming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"11","key":"4346_CR1","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3390\/cancers12113146","volume":"12","author":"A Rangel-Pozzo","year":"2020","unstructured":"Rangel-Pozzo A, Sisdelli L, Cordioli MIV, et al. Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations. Cancers. 2020;12(11):3146. https:\/\/doi.org\/10.3390\/cancers12113146.","journal-title":"Cancers"},{"issue":"12","key":"4346_CR2","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1001\/jamaoto.2024.1699","volume":"150","author":"H Levyn","year":"2024","unstructured":"Levyn H, Scholfield DW, Eagan A, et al. Outcomes of Conversion Surgery for Patients With Low-Risk Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg. 2024;150(12):1058. https:\/\/doi.org\/10.1001\/jamaoto.2024.1699.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"4","key":"4346_CR3","doi-asserted-by":"publisher","first-page":"932","DOI":"10.7150\/jca.33105","volume":"11","author":"J Ge","year":"2020","unstructured":"Ge J, Wang J, Wang H, et al. The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer. J Cancer. 2020;11(4):932\u20139. https:\/\/doi.org\/10.7150\/jca.33105.","journal-title":"J Cancer"},{"key":"4346_CR4","doi-asserted-by":"publisher","unstructured":"Dom\u00ednguez-Ayala M, M\u00ednguez-Gabi\u00f1a P, Paja-Fano M, Bilbao-Gonz\u00e1lez A, Exp\u00f3sito-Rodr\u00edguez A, Rode\u00f1o-Ortiz de Zarate E. The role of BRAF V600E mutation in post-surgical 131I therapy in papillary thyroid carcinoma: a study based on SPECT-CT uptake analysis. Q J Nucl Med Mol Imaging. 2023;67(1). https:\/\/doi.org\/10.23736\/s1824-4785.21.03343-4.","DOI":"10.23736\/s1824-4785.21.03343-4"},{"issue":"5","key":"4346_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3881\/j.issn.1000-503X.15845","volume":"46","author":"H Li","year":"2024","unstructured":"Li H, Zhang B. Correlation between ultrasound characteristics and gene mutations and pathological subtypes of papillary thyroid carcinoma. Acta Academiae Medicinae Sinicae. 2024;46(5):747\u201355. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.15845.","journal-title":"Acta Academiae Medicinae Sinicae"},{"key":"4346_CR6","doi-asserted-by":"publisher","unstructured":"Di Salvatore V, Gian\u00ec F, Russo G et al. Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression. 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). Published online November 2019:2202\u20132206. https:\/\/doi.org\/10.1109\/bibm47256.2019.8983036","DOI":"10.1109\/bibm47256.2019.8983036"},{"key":"4346_CR7","doi-asserted-by":"publisher","unstructured":"Menicali E, Guzzetti M, Morelli S, Moretti S, Puxeddu E. Immune Landscape of Thyroid Cancers: New Insights. Front Endocrinol. 2021;11. https:\/\/doi.org\/10.3389\/fendo.2020.637826.","DOI":"10.3389\/fendo.2020.637826"},{"issue":"6","key":"4346_CR8","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hed.27695","volume":"46","author":"B Febrero","year":"2024","unstructured":"Febrero B, Ruiz-Manzanera JJ, Ros\u2010Madrid I, Hern\u00e1ndez AM, Orenes\u2010Pi\u00f1ero E, Rodr\u00edguez JM. Tumor microenvironment in thyroid cancer: Immune cells, patterns, and novel treatments. Head Neck. 2024;46(6):1486\u201399. https:\/\/doi.org\/10.1002\/hed.27695.","journal-title":"Head Neck"},{"issue":"1","key":"4346_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","volume":"53","author":"X Zhang","year":"2020","unstructured":"Zhang X, Bai X, chen, Chen ZJ. Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway. Immunity. 2020;53(1):43\u201353. https:\/\/doi.org\/10.1016\/j.immuni.2020.05.013.","journal-title":"Immunity"},{"key":"4346_CR10","doi-asserted-by":"publisher","unstructured":"Yum S, Li M, Fang Y, Chen ZJ. TBK1 recruitment to STING activates both IRF3 and NF-\u03baB that mediate immune defense against tumors and viral infections. Proc Natl Acad Sci USA. 2021;118(14). https:\/\/doi.org\/10.1073\/pnas.2100225118.","DOI":"10.1073\/pnas.2100225118"},{"key":"4346_CR11","doi-asserted-by":"publisher","unstructured":"Li T, Cheng H, Yuan H, et al. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response. Sci Rep. 2016;6(1). https:\/\/doi.org\/10.1038\/srep19049.","DOI":"10.1038\/srep19049"},{"key":"4346_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20892\/j.issn.2095-3941.2023.0440","volume":"3","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yu S, Peng Q, Wang P, Fang L. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies. Cancer Biol Med Published online January. 2024;3:1\u201320. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0440.","journal-title":"Cancer Biol Med Published online January"},{"key":"4346_CR13","doi-asserted-by":"publisher","unstructured":"Huang Z, Zhu J, Zhou YL, Shi J. The cGAS-STING pathway: a dual regulator of immune response in cancer and therapeutic implications. J Transl Med. 2025;23(1). https:\/\/doi.org\/10.1186\/s12967-025-06843-2.","DOI":"10.1186\/s12967-025-06843-2"},{"key":"4346_CR14","doi-asserted-by":"publisher","first-page":"113447","DOI":"10.1016\/j.intimp.2024.113447","volume":"143","author":"Y Luo","year":"2024","unstructured":"Luo Y, Liang G, Zhang Q, Luo B. The role of cGAS-STING signaling pathway in colorectal cancer immunotherapy: Mechanism and progress. Int Immunopharmacol. 2024;143:113447. https:\/\/doi.org\/10.1016\/j.intimp.2024.113447.","journal-title":"Int Immunopharmacol"},{"issue":"43","key":"4346_CR15","doi-asserted-by":"publisher","first-page":"29439","DOI":"10.1021\/acsnano.3c12337","volume":"18","author":"SL Cheng","year":"2024","unstructured":"Cheng SL, Lee HM, Li CP, et al. Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy. ACS Nano. 2024;18(43):29439\u201356. https:\/\/doi.org\/10.1021\/acsnano.3c12337.","journal-title":"ACS Nano"},{"key":"4346_CR16","doi-asserted-by":"publisher","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21(1). https:\/\/doi.org\/10.1186\/s12943-022-01569-x.","DOI":"10.1186\/s12943-022-01569-x"},{"issue":"1","key":"4346_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","volume":"3","author":"S Colak","year":"2017","unstructured":"Colak S, ten Dijke P. Targeting TGF-\u03b2 Signaling in Cancer. Trends Cancer. 2017;3(1):56\u201371. https:\/\/doi.org\/10.1016\/j.trecan.2016.11.008.","journal-title":"Trends Cancer"},{"issue":"6","key":"4346_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","volume":"31","author":"L Yang","year":"2010","unstructured":"Yang L, Pang Y, Moses HL. TGF-\u03b2 and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010;31(6):220\u20137. https:\/\/doi.org\/10.1016\/j.it.2010.04.002.","journal-title":"Trends Immunol"},{"issue":"1","key":"4346_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","volume":"41","author":"W Chen","year":"2023","unstructured":"Chen W. TGF-\u03b2 Regulation of T Cells. Annu Rev Immunol. 2023;41(1):483\u2013512. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-045939.","journal-title":"Annu Rev Immunol"},{"key":"4346_CR20","doi-asserted-by":"crossref","unstructured":"Bai X, Yi M, Jiao Y, Chu Q, Wu K. Blocking TGF-\u03b2 Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor OTT. 2019;Volume 12:9527\u20139538. doi:10.2147\/ott.s224013.","DOI":"10.2147\/OTT.S224013"},{"key":"4346_CR21","doi-asserted-by":"publisher","unstructured":"Lain\u00e9 A, Labiad O, Hernandez-Vargas H, et al. Regulatory T cells promote cancer immune-escape through integrin \u03b1v\u03b28-mediated TGF-\u03b2 activation. Nat Commun. 2021;12(1). https:\/\/doi.org\/10.1038\/s41467-021-26352-2.","DOI":"10.1038\/s41467-021-26352-2"},{"key":"4346_CR22","doi-asserted-by":"publisher","unstructured":"Yi M, Niu M, Wu Y, et al. Combination of oral STING agonist MSA-2 and anti-TGF-\u03b2\/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors. J Hematol Oncol. 2022;15(1). https:\/\/doi.org\/10.1186\/s13045-022-01363-8.","DOI":"10.1186\/s13045-022-01363-8"},{"issue":"1","key":"4346_CR23","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1080\/10717544.2022.2094498","volume":"29","author":"B Li","year":"2022","unstructured":"Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Delivery. 2022;29(1):2130\u201361. https:\/\/doi.org\/10.1080\/10717544.2022.2094498.","journal-title":"Drug Delivery"},{"issue":"5","key":"4346_CR24","doi-asserted-by":"publisher","first-page":"052002","DOI":"10.1088\/2057-1976\/acedb2","volume":"9","author":"S Prakash","year":"2023","unstructured":"Prakash S. Nano-based drug delivery system for therapeutics: a comprehensive review. Biomed Phys Eng Express. 2023;9(5):052002. https:\/\/doi.org\/10.1088\/2057-1976\/acedb2.","journal-title":"Biomed Phys Eng Express"},{"issue":"7","key":"4346_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/pharmaceutics17070886","volume":"17","author":"YY Fan","year":"2025","unstructured":"Fan YY, Wu H, Xu C. ROS-Responsive Nanoplatforms for Targeted Tumor Immunomodulation: A Paradigm Shift in Precision Cancer Immunotherapy. Pharmaceutics. 2025;17(7):886. https:\/\/doi.org\/10.3390\/pharmaceutics17070886.","journal-title":"Pharmaceutics"},{"key":"4346_CR26","doi-asserted-by":"publisher","unstructured":"Huang Y, Ruan Y, Ma Y, et al. Immunomodulatory activity of manganese dioxide nanoparticles: Promising for novel vaccines and immunotherapeutics. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1128840.","DOI":"10.3389\/fimmu.2023.1128840"},{"key":"4346_CR27","doi-asserted-by":"publisher","unstructured":"Yang G, Xu L, Chao Y, et al. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat Commun. 2017;8(1). https:\/\/doi.org\/10.1038\/s41467-017-01050-0.","DOI":"10.1038\/s41467-017-01050-0"},{"key":"4346_CR28","doi-asserted-by":"publisher","unstructured":"Zhang Y, Meng D, Shi J et al. Manganese dioxide nanosheets-based redox\/pH-responsive drug delivery system for cancer theranostic application. IJN Published online April 2016:1759. https:\/\/doi.org\/10.2147\/ijn.s98832","DOI":"10.2147\/ijn.s98832"},{"key":"4346_CR29","doi-asserted-by":"publisher","unstructured":"Yang Q, Wu Q, Liu H, Wu J, Ma F, Tian X. Tumor microenvironment\u2013responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy. Front Pharmacol. 2025;15. https:\/\/doi.org\/10.3389\/fphar.2024.1518983.","DOI":"10.3389\/fphar.2024.1518983"},{"issue":"39","key":"4346_CR30","doi-asserted-by":"publisher","first-page":"16571","DOI":"10.1039\/d1nr04196g","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yang Y, Shi J, Wang L. A multimodal strategy of Fe3O4@ZIF-8\/GOx@MnO2hybrid nanozymeviaTME modulation for tumor therapy. Nanoscale. 2021;13(39):16571\u201388. https:\/\/doi.org\/10.1039\/d1nr04196g.","journal-title":"Nanoscale"},{"key":"4346_CR31","doi-asserted-by":"publisher","first-page":"106654","DOI":"10.1016\/j.oraloncology.2023.106654","volume":"148","author":"W Chen","year":"2024","unstructured":"Chen W, Yu X, Li H, et al. Single-cell RNA-seq reveals MIF\u2013(CD74\u2009+\u2009CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma. Oral Oncol. 2024;148:106654. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106654.","journal-title":"Oral Oncol"},{"issue":"15","key":"4346_CR32","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/cells12151970","volume":"12","author":"C Cheng","year":"2023","unstructured":"Cheng C, Chen W, Jin H, Chen X. A Review of Single-Cell RNA-Seq Annotation, Integration, and Cell\u2013Cell Communication. Cells. 2023;12(15):1970. https:\/\/doi.org\/10.3390\/cells12151970.","journal-title":"Cells"},{"issue":"5","key":"4346_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/cancers17050794","volume":"17","author":"JC Jaume","year":"2025","unstructured":"Jaume JC. Thyroid Cancer\u2014The Tumor Immune Microenvironment (TIME) over Time and Space. Cancers. 2025;17(5):794. https:\/\/doi.org\/10.3390\/cancers17050794.","journal-title":"Cancers"},{"issue":"20","key":"4346_CR34","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.3390\/ijms232012578","volume":"23","author":"E Shin","year":"2022","unstructured":"Shin E, Koo JS. Cell Component and Function of Tumor Microenvironment in Thyroid Cancer. IJMS. 2022;23(20):12578. https:\/\/doi.org\/10.3390\/ijms232012578.","journal-title":"IJMS"},{"issue":"2","key":"4346_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.can-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method. Cancer Res. 2010;70(2):440\u20136. https:\/\/doi.org\/10.1158\/0008-5472.can-09-1947.","journal-title":"Cancer Res"},{"key":"4346_CR36","doi-asserted-by":"publisher","unstructured":"Zhang LX, Gao J, Long X, et al. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p\/CARM1 axis. Mol Cancer. 2022;21(1). https:\/\/doi.org\/10.1186\/s12943-022-01586-w.","DOI":"10.1186\/s12943-022-01586-w"},{"issue":"12","key":"4346_CR37","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS\u2013STING pathway and cancer. Nat Cancer. 2022;3(12):1452\u201363. https:\/\/doi.org\/10.1038\/s43018-022-00468-w.","journal-title":"Nat Cancer"},{"key":"4346_CR38","doi-asserted-by":"publisher","unstructured":"Zhu Y, An X, Zhang X, Qiao Y, Zheng T, Li X. STING: a master regulator in the cancer-immunity cycle. Mol Cancer. 2019;18(1). https:\/\/doi.org\/10.1186\/s12943-019-1087-y.","DOI":"10.1186\/s12943-019-1087-y"},{"key":"4346_CR39","doi-asserted-by":"publisher","unstructured":"Lu X, Wang X, Cheng H, Wang X, Liu C, Tan X. Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway. Ann Med. 2023;55(1). https:\/\/doi.org\/10.1080\/07853890.2023.2210845.","DOI":"10.1080\/07853890.2023.2210845"},{"key":"4346_CR40","doi-asserted-by":"publisher","unstructured":"Zhang D, Zhan D, Zhang R, et al. Treg-derived TGF-\u03b21 dampens cGAS-STING signaling to downregulate the expression of class I MHC complex in multiple myeloma. Sci Rep. 2024;14(1). https:\/\/doi.org\/10.1038\/s41598-024-62298-3.","DOI":"10.1038\/s41598-024-62298-3"},{"key":"4346_CR41","doi-asserted-by":"publisher","unstructured":"Guerin MV, Regnier F, Feuillet V, et al. TGF\u03b2 blocks IFN\u03b1\/\u03b2 release and tumor rejection in spontaneous mammary tumors. Nat Commun. 2019;10(1). https:\/\/doi.org\/10.1038\/s41467-019-11998-w.","DOI":"10.1038\/s41467-019-11998-w"},{"issue":"1","key":"4346_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2020","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGF\u03b2 biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2020;18(1):9\u201334. https:\/\/doi.org\/10.1038\/s41571-020-0403-1.","journal-title":"Nat Rev Clin Oncol"},{"key":"4346_CR43","doi-asserted-by":"publisher","unstructured":"Yi L, Jiang X, Zhou Z, et al. A Hybrid Nanoadjuvant Simultaneously Depresses PD-L1\/TGF\u2010\u03b21 and Activates cGAS\u2010STING Pathway to Overcome Radio\u2010Immunotherapy Resistance. Adv Mater. 2024;36(15). https:\/\/doi.org\/10.1002\/adma.202304328.","DOI":"10.1002\/adma.202304328"},{"issue":"3","key":"4346_CR44","doi-asserted-by":"publisher","first-page":"e1004783","DOI":"10.1371\/journal.ppat.1004783","volume":"11","author":"Z Li","year":"2015","unstructured":"Li Z, Liu G, Sun L, et al. PPM1A Regulates Antiviral Signaling by Antagonizing TBK1-Mediated STING Phosphorylation and Aggregation. PLoS Pathog. 2015;11(3):e1004783. https:\/\/doi.org\/10.1371\/journal.ppat.1004783.","journal-title":"PLoS Pathog"},{"issue":"9","key":"4346_CR45","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/ma10090988","volume":"10","author":"Q Liu","year":"2017","unstructured":"Liu Q, Ji S, Yang J, Wang H, Pollet B, Wang R. Enhanced Cycleability of Amorphous MnO2 by Covering on \u03b1-MnO2 Needles in an Electrochemical Capacitor. Materials. 2017;10(9):988. https:\/\/doi.org\/10.3390\/ma10090988.","journal-title":"Materials"},{"key":"4346_CR46","doi-asserted-by":"publisher","unstructured":"Yang Y, Gu Z, Tang J, et al. MnO2 Nanoflowers Induce Immunogenic Cell Death under Nutrient Deprivation: Enabling an Orchestrated Cancer Starvation-Immunotherapy. Adv Sci. 2020;8(4). https:\/\/doi.org\/10.1002\/advs.202002667.","DOI":"10.1002\/advs.202002667"},{"issue":"11","key":"4346_CR47","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","volume":"30","author":"M Lv","year":"2020","unstructured":"Lv M, Chen M, Zhang R, et al. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res. 2020;30(11):966\u201379. https:\/\/doi.org\/10.1038\/s41422-020-00395-4.","journal-title":"Cell Res"},{"issue":"1","key":"4346_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21147\/j.issn.1000-9604.2023.01.04","volume":"35","author":"A Huang","year":"2023","unstructured":"Huang A, Zhou W. Mn-based cGAS-STING activation for tumor therapy. Chin J Cancer Res. 2023;35(1):19\u201343. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.01.04.","journal-title":"Chin J Cancer Res"},{"issue":"3","key":"4346_CR49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1124\/mol.65.3.744","volume":"65","author":"S DaCosta Byfield","year":"2004","unstructured":"DaCosta Byfield S, Major C, Laping NJ, Roberts AB. SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-\u03b2 Type I Receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2004;65(3):744\u201352. https:\/\/doi.org\/10.1124\/mol.65.3.744.","journal-title":"Mol Pharmacol"},{"issue":"7090","key":"4346_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235\u20138. https:\/\/doi.org\/10.1038\/nature04753.","journal-title":"Nature"},{"issue":"2","key":"4346_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jmcb\/mjs063","volume":"5","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Cui F, Fang L, Hong J, Zheng B, Zhang JZ. TNF-\u03b1 impairs differentiation and function of TGF-\u03b2-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway. J Mol Cell Biol. 2012;5(2):85\u201398. https:\/\/doi.org\/10.1093\/jmcb\/mjs063.","journal-title":"J Mol Cell Biol"},{"issue":"5","key":"4346_CR52","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.20131556","volume":"211","author":"S Srivastava","year":"2014","unstructured":"Srivastava S, Koch MA, Pepper M, Campbell DJ. Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. J Exp Med. 2014;211(5):961\u201374. https:\/\/doi.org\/10.1084\/jem.20131556.","journal-title":"J Exp Med"},{"issue":"1","key":"4346_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1021\/acsnano.5b06779","volume":"10","author":"M Song","year":"2015","unstructured":"Song M, Liu T, Shi C, Zhang X, Chen X. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia. ACS Nano. 2015;10(1):633\u201347. https:\/\/doi.org\/10.1021\/acsnano.5b06779.","journal-title":"ACS Nano"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04346-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:14:58Z","timestamp":1779671698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04346-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4346"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04346-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Aniphe Biolaboratory, China. Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"480"}}